177 related articles for article (PubMed ID: 10627470)
1. Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma.
Tinhofer I; Marschitz I; Henn T; Egle A; Greil R
Blood; 2000 Jan; 95(2):610-8. PubMed ID: 10627470
[TBL] [Abstract][Full Text] [Related]
2. Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis.
Frassanito MA; Cusmai A; Iodice G; Dammacco F
Blood; 2001 Jan; 97(2):483-9. PubMed ID: 11154226
[TBL] [Abstract][Full Text] [Related]
3. Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors.
Jourdan M; Mahtouk K; Veyrune JL; Couderc G; Fiol G; Redal N; Duperray C; De Vos J; Klein B
Eur Cytokine Netw; 2005; 16(1):57-64. PubMed ID: 15809207
[TBL] [Abstract][Full Text] [Related]
4. Fas/APO-1 (CD95)-mediated apoptosis is activated by interferon-gamma and interferon- in interleukin-6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines.
Spets H; Georgii-Hemming P; Siljason J; Nilsson K; Jernberg-Wiklund H
Blood; 1998 Oct; 92(8):2914-23. PubMed ID: 9763578
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin 16 in multiple myeloma.
Atanackovic D; Hildebrandt Y; Templin J; Cao Y; Keller C; Panse J; Meyer S; Reinhard H; Bartels K; Lajmi N; Sezer O; Zander AR; Marx AH; Uhlig R; Zustin J; Bokemeyer C; Kröger N
J Natl Cancer Inst; 2012 Jul; 104(13):1005-20. PubMed ID: 22745469
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid modulates the in vivo and in vitro growth of IL-6 autocrine human myeloma cell lines via induction of apoptosis.
Levy Y; Labaume S; Colombel M; Brouet JC
Clin Exp Immunol; 1996 Apr; 104(1):167-72. PubMed ID: 8603522
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast-like synoviocytes from rheumatoid arthritis patients express functional IL-15 receptor complex: endogenous IL-15 in autocrine fashion enhances cell proliferation and expression of Bcl-x(L) and Bcl-2.
Kurowska M; Rudnicka W; Kontny E; Janicka I; Chorazy M; Kowalczewski J; Ziółkowska M; Ferrari-Lacraz S; Strom TB; Maśliński W
J Immunol; 2002 Aug; 169(4):1760-7. PubMed ID: 12165497
[TBL] [Abstract][Full Text] [Related]
8. CD40 ligand triggered interleukin-6 secretion in multiple myeloma.
Urashima M; Chauhan D; Uchiyama H; Freeman GJ; Anderson KC
Blood; 1995 Apr; 85(7):1903-12. PubMed ID: 7535594
[TBL] [Abstract][Full Text] [Related]
9. Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status.
Egle A; Villunger A; Marschitz I; Kos M; Hittmair A; Lukas P; Grünewald K; Greil R
Br J Haematol; 1997 May; 97(2):418-28. PubMed ID: 9163609
[TBL] [Abstract][Full Text] [Related]
10. Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis.
Shima Y; Nishimoto N; Ogata A; Fujii Y; Yoshizaki K; Kishimoto T
Blood; 1995 Feb; 85(3):757-64. PubMed ID: 7530506
[TBL] [Abstract][Full Text] [Related]
11. Immune reconstitution after autologous peripheral blood progenitor cell transplantation: effect of interleukin-15 on T-cell survival and effector functions.
Rutella S; Pierelli L; Bonanno G; Mariotti A; Sica S; Sorà F; Chiusolo P; Scambia G; Rumi C; Leone G
Exp Hematol; 2001 Dec; 29(12):1503-16. PubMed ID: 11750110
[TBL] [Abstract][Full Text] [Related]
12. TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells.
Gazitt Y
Leukemia; 1999 Nov; 13(11):1817-24. PubMed ID: 10557057
[TBL] [Abstract][Full Text] [Related]
13. The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype.
Yaccoby S
Clin Cancer Res; 2005 Nov; 11(21):7599-606. PubMed ID: 16278377
[TBL] [Abstract][Full Text] [Related]
14. Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I in myeloma cells that highly express IL-6 receptor alpha [corrected].
Abroun S; Ishikawa H; Tsuyama N; Liu S; Li FJ; Otsuyama K; Zheng X; Obata M; Kawano MM
Blood; 2004 Mar; 103(6):2291-8. PubMed ID: 14592826
[TBL] [Abstract][Full Text] [Related]
15. A potential role for interleukin-15 in the regulation of human natural killer cell survival.
Carson WE; Fehniger TA; Haldar S; Eckhert K; Lindemann MJ; Lai CF; Croce CM; Baumann H; Caligiuri MA
J Clin Invest; 1997 Mar; 99(5):937-43. PubMed ID: 9062351
[TBL] [Abstract][Full Text] [Related]
16. Marrow stromal cells induce B7-H1 expression on myeloma cells, generating aggressive characteristics in multiple myeloma.
Tamura H; Ishibashi M; Yamashita T; Tanosaki S; Okuyama N; Kondo A; Hyodo H; Shinya E; Takahashi H; Dong H; Tamada K; Chen L; Dan K; Ogata K
Leukemia; 2013 Feb; 27(2):464-72. PubMed ID: 22828443
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 10 abolishes the growth inhibitory effects of all-trans retinoic acid on human myeloma cells.
Otsuki T; Yata K; Sakaguchi H; Kurebayashi J; Matsuo Y; Uno M; Fujii T; Eda S; Isozaki Y; Yawata Y; Yamada O; Wada H; Sugihara T; Ueki A
Br J Haematol; 2002 Mar; 116(4):787-95. PubMed ID: 11886382
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells.
Hata H; Xiao H; Petrucci MT; Woodliff J; Chang R; Epstein J
Blood; 1993 Jun; 81(12):3357-64. PubMed ID: 8507873
[TBL] [Abstract][Full Text] [Related]
19. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
20. Increased function and survival of IL-15-transduced human dendritic cells are mediated by up-regulation of IL-15Ralpha and Bcl-2.
Tourkova IL; Yurkovetsky ZR; Gambotto A; Makarenkova VP; Perez L; Balkir L; Robbins PD; Shurin MR; Shurin GV
J Leukoc Biol; 2002 Nov; 72(5):1037-45. PubMed ID: 12429727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
